ConductScience.org, home

Gene · 4986

Drugs44

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
DIFELIKEFALIN ACETATECHEMBL5315123Kappa opioid receptor agonistAGONISTChEMBL
HYDROCODONECHEMBL1457Opioid receptors; mu/kappa/delta agonistAGONISTChEMBL
HYDROCODONE BITARTRATECHEMBL3989677Opioid receptors; mu/kappa/delta agonistAGONISTChEMBL
HYDROCODONE POLISTIREXCHEMBL1201470Opioid receptors; mu/kappa/delta agonistAGONISTChEMBL
LEVALLORPHANCHEMBL1254682Kappa opioid receptor partial agonistPARTIAL AGONISTChEMBL
LEVALLORPHAN TARTRATECHEMBL2062276Kappa opioid receptor partial agonistPARTIAL AGONISTChEMBL
NALBUPHINECHEMBL895Opioid receptors; mu/kappa/delta agonistAGONISTChEMBL
NALBUPHINE HYDROCHLORIDECHEMBL1201132Opioid receptors; mu/kappa/delta agonistAGONISTChEMBL
NALFURAFINECHEMBL267495Kappa opioid receptor agonistAGONISTChEMBL
NALFURAFINE HYDROCHLORIDECHEMBL490665Kappa opioid receptor agonistAGONISTChEMBL
NALMEFENECHEMBL982Kappa opioid receptor partial agonistPARTIAL AGONISTChEMBL
NALMEFENE HYDROCHLORIDE DIHYDRATECHEMBL5315055Kappa opioid receptor partial agonistPARTIAL AGONISTChEMBL
NALOXONECHEMBL80Opioid receptors; mu/kappa/delta antagonistANTAGONISTChEMBL
NALOXONE HYDROCHLORIDECHEMBL1718Opioid receptors; mu/kappa/delta antagonistANTAGONISTChEMBL
NALOXONE HYDROCHLORIDE DIHYDRATECHEMBL5315056Opioid receptors; mu/kappa/delta antagonistANTAGONISTChEMBL
NALTREXONECHEMBL19019Opioid receptors; mu/kappa/delta antagonistANTAGONISTChEMBL
NALTREXONE HYDROCHLORIDECHEMBL1201149Opioid receptors; mu/kappa/delta antagonistANTAGONISTChEMBL
NAVACAPRANTCHEMBL4592045Kappa opioid receptor antagonistANTAGONISTChEMBL
ONDELOPRANCHEMBL2103878Opioid receptors; mu/kappa/delta antagonistANTAGONISTChEMBL
ORP-101CHEMBL4594402Kappa opioid receptor antagonistANTAGONISTChEMBL

gene-search-2026-11-11-0.1.0

Sources 11

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNone stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GeneNone named. Public domain as US government information
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/4986/drugs?page=2